SEGMENT REPORTING (Tables)

3 Months Ended

Mar. 31, 2013

Segment Reporting [Abstract]

Schedule of certain information of these segments

	Quarter Ended March 31,
	2013			2012
Revenues
Surgical products	$	14,483		$	15,494
Brachytherapy seed		5,719			6,320
Intersegment eliminations		(329	)		(231	)
	$	19,873		$	21,583
Earnings (loss) from operations
Surgical products	$	(335	)	$	199
Brachytherapy seed		399			1,380
Intersegment eliminations		(47	)		(3	)
	$	17		$	1,576
Capital expenditures
Surgical products	$	412		$	272
Brachytherapy seed		115			57
	$	527		$	329
Depreciation and amortization
Surgical products	$	1,236		$	1,229
Brachytherapy seed		768			754
	$	2,004		$	1,983

Schedule of supplemental information related to significant assets

	March 31, 2013			December 31, 2012
Identifiable assets
Surgical products	$	69,965		$	70,361
Brachytherapy seed		61,577			62,474
Corporate investment in subsidiaries		111,439			111,439
Intersegment eliminations		(137,854	)		(138,549	)
	$	105,127		$	105,725
Intangible assets
Surgical products	$	5,958		$	6,644
Brachytherapy seed		4,167			4,376
	$	10,125		$	11,020

Schedule of information regarding revenue by geographic regions

	Quarter Ended March 31,
	2013		2012
Product sales
United States	$	16,012	$	18,948
Europe		2,203		1,509
Other foreign countries		997		522
		19,212		20,979
License and fee income
United States		268		247
Canada		393		357
		661		604
	$	19,873	$	21,583